Frontlight ResearchEarly access
Trial site
California Neuroscience Research, LLC
- 1running trial
- 5closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Migraine1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Engrail Therapeutics INC2 trials
- Biogen1 trial
- Pfizer1 trial
Running trials
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Closed trials
Completed
A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Completed
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Completed
ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Completed
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Site data: ClinicalTrials.govUpdated 15 Nov 2026